GTR Home > Tests > Search results - Noonan syndrome 6

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C2750732[DISCUI]

C Clinical test, R Research test

Showing 1 to 13 of 13 tests for 1 condition in 6 labs

CNoonan syndrome type 6

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNoonan Spectrum Disorders Panel (12 Genes) 

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (17)
Total targets (12)

CNoonan Spectrum Disorders/Rasopathies NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (12)

CNoonan Syndrome via the NRAS Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNoonan Syndrome Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (7)
Total targets (7)

CNoonan spectrum disorders

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (12)

CNoonan syndrome

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (13)
Total targets (12)

CCardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (229)
Total targets (104)

CThyroid Cancer NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (72)
Total targets (10)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (599)
Total targets (342)

CNoonan Syndrome NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (11)

CNoonan Syndrome: NRAS Gene Deletion/Duplication

Test targets
Methods
  • D Deletion/duplication analysis

CTest for NRAS-Related Noonan Syndrome

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • D Deletion/duplication analysis

Showing 1 to 13 of 13 tests for 1 condition in 6 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk